Cargando…
Clinicopathological characterization of SMAD4-mutated intestinal adenocarcinomas: A case-control study
The SMAD4 tumor suppressor gene product inhibits transforming growth factor-β-mediated signaling and is mutated in ~10% of colorectal carcinomas. The prognostic significance of SMAD4 mutations has been controversial. We studied the pathological and clinical characteristics of SMAD4-mutated intestina...
Autores principales: | Liao, Xiaoyan, Hao, Yansheng, Zhang, Xiaofei, Ward, Stephen, Houldsworth, Jane, Polydorides, Alexandros D., Harpaz, Noam |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6366887/ https://www.ncbi.nlm.nih.gov/pubmed/30730996 http://dx.doi.org/10.1371/journal.pone.0212142 |
Ejemplares similares
-
Isolated Gastric Metastasis of Endometrial Adenocarcinoma: First Case Report and Review of Pertinent Literature
por: Cui, Min, et al.
Publicado: (2018) -
A study of Smad4, Smad6 and Smad7 in Surgically Resected Samples of Pancreatic Ductal Adenocarcinoma and Their Correlation with Clinicopathological Parameters and Patient Survival
por: Singh, Puneet, et al.
Publicado: (2011) -
Clinicopathological Characterization and Prognostic Implication of SMAD4 Expression in Colorectal Carcinoma
por: Yoo, Seung-Yeon, et al.
Publicado: (2019) -
Clinicopathological significance of SMAD4 loss in pancreatic ductal adenocarcinomas: a systematic review and meta-analysis
por: Wang, Jin-Dao, et al.
Publicado: (2016) -
Analysis of the Clinicopathologic Characteristics of Lung Adenocarcinoma With CTNNB1 Mutation
por: Zhou, Chao, et al.
Publicado: (2020)